Vis’ Yuvezzi Receives Approval in US
28 Jan 2026 //
FDA
Tenpoint-Therapeutics-Receives US FDA Approval YUVEZZI
28 Jan 2026 //
PRESS RELEASE
Visus & Zhaoke Enter Excl. Licensing Agreement for BRIMOCHOL PF, Carbachol PF
11 May 2022 //
BUSINESSWIRE
28 Jan 2026 //
FDA
28 Jan 2026 //
PRESS RELEASE
11 May 2022 //
BUSINESSWIRE
Market Place
Sourcing Support